NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,375,725 | -13.3% | 33,150 | +25.7% | 0.00% | -20.0% |
| Q1 2023 | $1,586,313 | -37.1% | 26,377 | -23.2% | 0.01% | -37.5% |
| Q4 2022 | $2,520,526 | -16.1% | 34,363 | -13.0% | 0.01% | -11.1% |
| Q3 2022 | $3,003,000 | +64.7% | 39,519 | +50.6% | 0.01% | +50.0% |
| Q2 2022 | $1,823,000 | +18.9% | 26,234 | +41.8% | 0.01% | +50.0% |
| Q1 2022 | $1,533,000 | +7.4% | 18,500 | -2.6% | 0.00% | 0.0% |
| Q4 2021 | $1,427,000 | -30.6% | 19,000 | +7.3% | 0.00% | -33.3% |
| Q3 2021 | $2,056,000 | -49.3% | 17,700 | -3.3% | 0.01% | -50.0% |
| Q2 2021 | $4,059,000 | +61.6% | 18,300 | -3.7% | 0.01% | +50.0% |
| Q1 2021 | $2,511,000 | -49.4% | 19,000 | -33.8% | 0.01% | -46.7% |
| Q4 2020 | $4,966,000 | – | 28,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |